In this episode, a patient shares her journey from undiagnosed Hereditary Angioedema (HAE) in childhood, through battles with severe attacks as an adult, to two years attack-free and counting due to a clinical trial with a new prophylactic treatment option, ANDEMBRY ® (garadacimab-gxii). She emphasizes resilience and the importance of exploring new treatment options, which has allowed her to live attack-free for the first time in decades.

Her story is a testament to the power of not settling for “good enough” and the transformative impact of innovative treatments. Her doctor offers a medical perspective on the clinical impact of ANDEMBRY ®. Visit ANDEMBRY.com to learn more.

Thank you to our sponsor: CSL Behring